Drawing for BENITEC

USPTO serial 76492932

BENITEC

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
EDWARDS, ALICIA COLLINS
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BENITEC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott A.M. Chambers

SCOTT A M CHAMBERS PATTON BOGGS LLP8484 WESTPARK DR STE 900MCLEAN, VA 22102-5117UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic preparations for scientific and research use, namely, preparations containing synthetic nucleic acid, including synthetic DNA, cloned DNA and recombinant DNA; synthetic RNA, cloned RNA and recombinant RNA; DNA and RNA for scientific and research use in the fields of agricultural and industrial biotechnology; DNA and RNA and preparations containing DNA and/or RNA for scientific and research use in the regulation and/or expression of mammalian, human, plant, microbial and synthetic genes for use in the fields of pharmaceutical research and agricultural and industrial biotechnology; pharmaceutical and other diagnostic preparations for scientific and research use in the fields of agricultural and industrial biotechnology; pharmaceutical and other preparations for use in the field of pharmaceutical research; yeast, fungi, tissue culture of plants, and genetically modified examples thereof for scientific or research useACTIVE—
005Diagnostic preparations for clinical and medical and/or veterinary laboratory use, namely, DNA and/or RNA and preparations containing DNA and/or RNA for the regulation and expression of mammalian, human, plant, microbial and synthetic genes for use in the fields of human and veterinary therapeutics; medicinal and biological preparations for clinical or medical laboratory use including preparations for the modification of gene expression; medicinal and biological preparations for pharmaceutical use in the treatment of AIDS, HIV, Hepatitis B and C, viral infections and diseases, cancers, bacterial infections, central nervous system disorders, diabetes, obesity, genetic disorders and genetic illnesses, autoimmune, inflammatory; immunodeficiency, respiratory, cardiovascular and urologic diseases; pharmaceutical and other preparations for use in the fields of human and veterinary therapeutics in the treatment of AIDS, HIV, Hepatitis B and C, viral infections and diseases, cancers, bacterial infections, central nervous system disorders, diabetes, obesity, genetic disorders and genetic illnesses, autoimmune, inflammatory; immunodeficiency, respiratory, cardiovascular and urologic diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Nov 16, 2006MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 16, 2006ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 29, 2006ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 29, 2006REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 8, 2006EX2GSOU EXTENSION 2 GRANTED—
Mar 8, 2006EXT2SOU EXTENSION 2 FILED—
Mar 8, 2006EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 13, 2005EX1GSOU EXTENSION 1 GRANTED—
Sep 7, 2005EXT1SOU EXTENSION 1 FILED—
Sep 7, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 7, 2005ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 7, 2005REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 8, 2005NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 14, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 24, 2004NPUBNOTICE OF PUBLICATION—
Sep 20, 2004MAILPAPER RECEIVED—
Sep 3, 2004PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 3, 2004ALIEASSIGNED TO LIE—
Sep 3, 2004ALIEASSIGNED TO LIE—
Aug 23, 2004ALIEASSIGNED TO LIE—
Aug 11, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 12, 2004ACECAMENDMENT FROM APPLICANT ENTERED—
Jul 12, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 12, 2004MAILPAPER RECEIVED—
Jul 9, 2004FAXXFAX RECEIVED—
May 3, 2004CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 17, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 17, 2004MAILPAPER RECEIVED—
Feb 13, 2004FAXXFAX RECEIVED—
Feb 13, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 21, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 14, 2003DOCKASSIGNED TO EXAMINER—
Aug 14, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance